Diana Chávez Muñoz

Dr. Diana Chávez Muñoz

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
GDGilberto Duarte-Medrano
Gilberto Duarte-Medrano
NNNatalia Nuño-Lámbarri
Natalia Nuño-Lámbarri
DMDiana Chávez Muñoz
Diana Chávez Muñoz
RERebeca Garazi Elguezabal-Rodelo
Rebeca Garazi Elguezabal-Rodelo
OGOctavio Gonzalez-Chon
Octavio Gonzalez-Chon
Luigi La ViaLuigi La Via
Luigi La Via
Background/Objectives: Intraoperative hypotension (IOHs) affects up to 87% of patients under general anesthesia and is consistently associated with acute kidney injury, myocardial damage, stroke, and mortality. The intermittent unavailability of ephedrine across healthcare systems underscores the need for evidence-based alternatives. This review critically evaluates pharmacological options for IOH when ephedrine is unavailable, focusing on receptor pharmacodynamics, population-specific evidence, and clinical consequences of inadequately managed hypotension. Methods: A narrative, evidence-based review was conducted examining mechanisms of action, dosing strategies, adverse effect profiles, and clinical applicability of key vasoactive agents: ephedrine, phenylephrine, norepinephrine, and epinephrine. Population-specific evidence across obstetric, pediatric, and elderly cohorts was synthesized from randomized controlled trials, meta-analyses, and observational studies. The clinical impact of IOH on neurological, cardiovascular, and renal outcomes was reviewed. Results: Each vasopressor exhibits a distinct receptor-selectivity profile that determines its hemodynamic effect and optimal clinical context. Norepinephrine’s favorable α1/β1 balance tends to preserve cardiac output better than pure α1-agonists and has emerged as a promising alternative in obstetric and elderly populations, although the optimal agent ultimately depends on the underlying mechanism of hypotension and individual patient characteristics. Epinephrine provides combined vasopressor and inotropic support for hypotension with myocardial depression. IOH is associated with a greater than twofold increase in postoperative AKI and significantly elevated risks of myocardial infarction and stroke, with outcomes driven by cumulative hypotensive exposure rather than isolated pressure nadirs. Conclusions: Effective management of IOH requires individualized vasopressor selection guided by underlying pathophysiology, cardiovascular profile, and surgical context. A physiology-based strategy—rather than protocol-driven drug substitution—enables anesthesiologists to achieve precise hemodynamic control and preserve end-organ perfusion even when ephedrine is unavailable.

7 January 2025
Verified
Book Chapter
Open access
PDF file
DNDiocelina Navarro-Bastida
Diocelina Navarro-Bastida
SZSergio Zavala-Vega
Sergio Zavala-Vega
NGNoemi Gelista-Herrera
Noemi Gelista-Herrera
NVNatalia Villa-Corral
Natalia Villa-Corral
DMDiana Chávez Muñoz
Diana Chávez Muñoz
AOAlma Ortiz-Plata
Alma Ortiz-Plata
Pituitary neuroendocrine tumors (PitNets) are considered benign, but can be invasive. They are classified by their size (microadenomas, macroadenomas, and giant adenomas), by their clinical manifestations (functioning, non-functioning), and by the hormonal content detected by immunocytochemistry. PitNets show slow growth, occupying the sellar region and invading adjacent structures. Their size and invasion have been analyzed using different radiological techniques, complemented by surgical observations and pathological findings. We also include the analysis of the frequency and degree of invasion of functioning and non-functioning PitNets in patients at the National Institute of Neurology and Neurosurgery in Mexico City. The analysis of the size and determination of the invasion degree of PitNets, in relation to the clinical presentation characteristics and hormonal content, allows a better understanding of the behavior of these tumors, which is crucial in planning both the surgical strategy and the follow-up, since size is related to the disease evolution.